Clinical Pharmacokinetics

The Impact of Efflux Transporters in the Brain on the Development of Drugs for CNS Disorders
pp. 81-92(12)
Author: Taylor E.M.

Cellular and Clinical Pharmacology of Fludarabine
pp. 93-103(11)
Authors: Gandhi V.; Plunkett W.

Pharmacokinetic Profile of Zafirlukast
pp. 105-114(10)
Authors: Dekhuijzen P.N.R.; Koopmans P.P.

Immunosuppressive Therapy for Paediatric Transplant Patients: Pharmacokinetic Considerations
pp. 115-135(21)
Authors: Fernández de Gatta M.d.M.; Santos-Buelga D.; Domínguez-Gil A.; García M.J.

Population Pharmacokinetic-Pharmacodynamic Modelling of Angiotensin Receptor Blockade in Healthy Volunteers
pp. 137-152(16)
Authors: Csajka C.; Buclin T.; Fattinger K.; Brunner H.R.; Biollaz J.

Population Pharmacokinetics of Haloperidol Using Routine Clinical Pharmacokinetic Data in Japanese Patients
pp. 153-159(7)
Authors: Yukawa E.; Hokazono T.; Yukawa M.; Ichimaru R.; Maki T.; Matsunaga K.; Ohdo S.; Anai M.; Higuchi S.; Goto Y.